Health economics and reimbursement
Analyses of the economic value and market access of healthcare products.
Discuss your studyEconomic evaluation and market access
Health economics studies consider the costs and benefits of healthcare products together. Reviewing clinical and economic evidence informs health technology assessment (HTA), market access and reimbursement planning. Lumen Clinical provides health economic analyses and consultancy for reimbursement processes.
- Health economic analyses
- Market access and reimbursement planning
- Value proposition development
- Health technology assessment (HTA)
What to share for an initial discussion
Defining the decision to be supported helps establish the scope of an analysis. Available evidence and additional data needs are reviewed against that objective and the application plan.
- Product, intended use and the decision the analysis should inform
- Available clinical evidence, cost data and alternatives for comparison
- Current market access or reimbursement stage and planned timeline